Stock·NYSE·Financial Services
The Travelers Companies, Inc. (TRV)
- Market cap
- $81.25B
- P/E
- 10.46
- Dividend yield
- 1.21%
- Street target
- $359.50median of 29 analysts
- 52-week range
- $262.90 $398.70
The short version
Where TRV stands today, in four lines, and what CleaRank Financial AI makes of it.
TRV at a glance
The Travelers Companies, Inc. (TRV): Buy, 77/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($369.28 and $324.11).
- Earnings TRV beat estimates in 8 of its last 8 quarters, yet fell the next day after 2 of those beats.
- Insiders Insiders sold $163.8M and made no open-market purchases over the last 18 months.
- Valuation P/E of 10.5 against 16.5 for the Financial Services sector: a discount to peers (-37%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates The Travelers Companies, Inc. (TRV) a Buy with a model score of 77/100.
Trend adds the most to that score. The price is 20.12% above its 200-day average and 5.43% above its 50-day average, and the 50-day average is 13.94% above the 200-day. Slow revenue growth pulls the score down the most, with revenue up 0.30%, 11.4 percentage points behind the sector median. The 50-day average is $369.28 and the 200-day is $324.11. The price has climbed 48.84% over the last year.
Only on CleaRank
Figures we compute ourselves from TRV's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $389.33 is 5.4% above the 50-day simple moving average of $369.28.Price above its 200-day average ›
The price is 20.1% above the 200-day simple moving average of $324.11.50-day average above the 200-day ›
The 50-day average ($369.28) is 13.9% above the 200-day average ($324.11), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 93% of its 52-week range, between $262.90 and $398.70.
TRV share price
Pick a period: each tab shows how far TRV has moved over it, to the last close.
Today's trading
Where TRV sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 10.46 is 36.6% below the Financial Services median of 16.5.P/S below the sector median ›
The price-to-sales ratio of 1.66 is 56.3% below the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was $8.2B on revenue of $49.0B, a net margin of 16.8%.Beat estimates in most recent reports ›
TRV beat the EPS estimate in 8 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 1.21%, or $4.70 a share a year.
Key statistics
The headline figures for TRV.
As of October 17, 2026, TRV trades at $389.33, with a market value of $81.25B, a P/E ratio of 10.46 and a dividend yield of 1.21%.
What the numbers say
CleaRank Financial AI's reading of TRV's valuation, growth and risks.
Measured against the 16.5 median P/E of Financial Services stocks, the P/E of The Travelers Companies, Inc. (TRV) at 10.46 sits 36.6% below that median, which marks it as a discount to peers. On sales, TRV trades at 1.66 times, which is 56.3% below the sector median of 3.8.
Revenue growth of 0.30% leaves TRV 11.4 percentage points slower than the sector median of 11.7%. Even so, the company turns sales into profit well, keeping 16.95% of revenue as net profit and posting an operating margin of 23.70%. Its return on equity of 26.51% sits above the sector median of 13.8%. On the balance sheet, debt-to-equity is 0.27, and the trailing dividend yield is 1.21%, or $4.70 a share each year.
The July 17, 2026 report showed EPS of $10.04 against an estimate of $5.39, beating the estimate by 86.27%. Even so, the stock slipped 0.13% in the next session.
TRV has beaten the EPS estimate in all 8 of its recent reports, but beats have not guaranteed gains: the stock fell the next day after 2 of them. Analysts' average EPS estimate for this fiscal year is $34.56, which would be growth of 25.3%, and $30.48 for next year (a decline of 11.8%).
Plan for day-to-day swings first: on an average session TRV moves 1.08%. On insider activity, $163.8M of stock was sold over the last 18 months and no shares were bought on the open market. Sales like these are often arranged ahead of time, so they carry less weight than purchases would.
TRV against the Financial Services sector
How TRV compares with the median Financial Services stock CleaRank tracks.
Price to earnings vs sector: TRV trades at a notable discount to sector peers (-37%), which may indicate undervaluation or specific company headwinds.
Return vs XLF: Since May 6, 2025, TRV has gained 45.3% against a gain of 12.5% for XLF.
Performance against XLF
TRV and the Financial Services sector fund over the same days.
Revenue and earnings
How much TRV sells, and how much of it becomes profit.
Revenue growth: Revenue grew 5.2% in FY2025 to $48.8B, from $46.4B a year earlier.
Profit margin: The net margin was 12.9% in FY2025, up from 10.8% the year before.
Profitable: TRV earned $6.3B in FY2025.
Earnings reality check
Did TRV beat what analysts expected, and how did the stock react?
Earnings record: TRV beat the analyst estimate in 8 of the last 8 quarters.
Market reaction: The stock fell in the first session after 2 of those 8 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 17, 2026after close | $5.39 | $10.04 | +86.27% | -0.13% | +4.95% |
| Apr 16, 2026after close | $7.08 | $7.71 | +8.90% | +0.66% | +2.84% |
| Jan 21, 2026after close | $8.92 | $11.06 | +23.99% | +2.14% | +3.44% |
| Oct 16, 2025after close | $6.38 | $8.14 | +27.59% | +0.17% | +2.88% |
| Jul 17, 2025after close | $3.61 | $6.51 | +80.33% | +1.59% | +0.07% |
| Apr 16, 2025after close | $0.77 | $1.91 | +148.05% | +1.34% | +3.14% |
| Jan 22, 2025after close | $6.67 | $8.96 | +34.33% | -2.11% | +1.13% |
| Oct 17, 2024after close | $3.60 | $5.42 | +50.56% | +0.24% | -3.17% |
As of October 17, 2026, TRV has beaten the analyst EPS estimate in 8 of its last 8 reported quarters and fell in the first trading session after 2 of those beats; its latest report, on July 17, 2026, came in 86.27% above the estimate and the stock moved -0.13% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 72.5, in overbought territory.RSI above 50 ›
An RSI of 72.5 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of TRV
The score, the reasoning behind it, and what could move the price next.
The Travelers Companies, Inc. (TRV) is trending up. The stock trades at $389.33, 5.43% above its 50-day average of $369.28 and 20.12% above its 200-day average of $324.11. It also sits near the top of its 52-week range: 2.35% below the high of $398.70 and 48.09% above the low of $262.90. Because the 50-day average is 13.94% above the 200-day, the longer-term picture agrees with the recent move.
Momentum is running hot: the 14-day RSI of 72.5 sits in overbought territory, and the MACD line is positive. Returns agree across every window shown, with the price up 5.52% over three months, 29.43% over six months and 48.84% over the past year. In the last session, volume came in 144.3% above its average while the price rose 1.42%.
Earnings beat ›
The July 17, 2026 report beat the EPS estimate by 86.27%, and the share price fell 0.13% in the first session after it.
Source: Earnings report, July 17, 2026
Rating reaffirmed ›
Wells Fargo kept its Equal-Weight rating on October 12, 2026.
Source: Analyst action, Wells Fargo, October 12, 2026
- Keep an eye on the two closest levels: the 52-week high at $398.70 sits above the price, and the 20-day EMA at $371.15 sits below it.
- A 14-day RSI of 72.5 places TRV in the overbought zone, and the MACD line is positive. Readings above 70 or below 30 point to stretched momentum.
- TRV beat estimates in 8 of the last 8 reports, yet after the July 17, 2026 report the share price fell 0.13% in the first session.
TRV's uptrend depends on the price holding above its 50-day average of $369.28 and its 200-day average of $324.11. A close below the 50-day would be the first sign that the trend is weakening. If the price pulls back, the first level it would reach is the 20-day EMA at $371.15.
The 52-week high at $398.70 is the next level overhead. The RSI is stretched above the overbought line, so a cooling of momentum would not be unusual even inside the uptrend.
Technical indicators
Momentum and trend for TRV, from its daily closes.
As of October 17, 2026, with TRV at $389.33, its 14-day RSI is 72.5 (overbought territory), its 50-day simple moving average is $369.28 and its 200-day is $324.11.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What TRV moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, TRV's 1-year correlation of daily returns is +0.24 with S&P 500 (SPY), +0.07 with Nasdaq 100 (QQQ), -0.12 with Bitcoin (BTC) and +0.01 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
0/3Most analysts rate it a buy ›
6 of 29 analysts rate it a buy or strong buy, 17 a hold and 6 a sell.Median target above the price ›
The median 12-month target of $359.50 is 7.7% below the price.More buy ratings than three months ago ›
6 of 29 rate it a buy now, against 6 of 29 three months ago.
TRV Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 12, 2026 | Wells Fargo | Maintains | Equal-Weight |
| Oct 9, 2026 | JP Morgan | Maintains | Neutral |
| Oct 7, 2026 | Mizuho | Maintains | Neutral |
| Oct 7, 2026 | Cantor Fitzgerald | Maintains | Overweight |
| Sep 21, 2026 | Evercore ISI Group | Maintains | In-Line |
| Sep 16, 2026 | Mizuho | Maintains | Neutral |
As of October 17, 2026, 29 Wall Street analysts cover TRV: 6 rate it a buy or strong buy, 17 a hold and 6 a sell or strong sell. Their 12-month price targets range from $262.00 to $430.00, with a median of $359.50, 7.7% below the price of $389.33.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
TRV trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from TRV's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much TRV tends to move, against the market and on its own.
The long record
TRV's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.08% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 42.9%, from July 2019 to March 2020, regained by February 2021.Most 1-year holds ended higher ›
83% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $41,863, against $42,058 in the S&P 500 (SPY).
TRV Drawdowns & Recovery
As of October 17, 2026, TRV's worst peak-to-trough fall over the last 10 years with dividends reinvested was -42.9% (July 2019 to March 2020); it regained that peak by February 2021, 11 months after the low, and 83% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into TRV in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: TRV trailed the S&P 500 over this period: $41,863 against $42,058.
A $10,000 investment in TRV in October 2016 would be worth about $41,863 today with dividends reinvested, compared with about $42,058 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to TRV, and which have not.
Strongest month, November: an average of +4.97%, up in 8 of 10 years.
Weakest month, March: an average of -1.63%, up in 5 of 10 years.
This month, October: has averaged +3.46%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, TRV's strongest calendar month has been November (average +4.97%, up in 8 of 10 years) and its weakest March (average -1.63%, up in 5 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in TRV, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in TRV today could grow to about $23,015 by 2036 in the base case, with a 90th-percentile outcome near $63,525 and a 10th-percentile outcome around $8,339. The simulation models price only; at today's 1.21% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
TRV Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $543 for TRV by 2030 in the base case, from $389 today (1.4x over 4 years). The 10th-percentile path ends near $286. These are outcomes of a Monte Carlo simulation run on TRV's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $307 | $423 | $583 | |
| 2028 | $292 | $460 | $724 | |
| 2029 | $287 | $500 | $872 | |
| 2030 | $286 | $543 | $1,033 | |
| 2031 | $288 | $591 | $1,211 |
Method: a lognormal simulation of TRV's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
TRV insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought TRV shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, TRV insiders reported 58 open-market sales worth $163.8M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 28, 2026 | Maria Olivo
Officer
|
Sell | 6.0K | $2.2M |
| Aug 14, 2026 | Anthony M Jabbour
Director
|
Grant | 446 | $165.2K |
| Jul 24, 2026 | Daniel Tei-Hwa Yin
Chief Investment Officer
|
Sell | 7.2K | $2.8M |
| Jul 24, 2026 | Diane Kurtzman
Officer
|
Sell | 4.2K | $1.6M |
| Jul 24, 2026 | Diane Kurtzman
Officer
|
Option | 4.2K | $552.1K |
| Jul 24, 2026 | Daniel Tei-Hwa Yin
Chief Investment Officer
|
Option | 7.2K | $1.0M |
| Jul 22, 2026 | David Donnay Rowland
Chief Investment Officer
|
Sell | 5.0K | $1.9M |
| Jul 22, 2026 | Andy F Bessette
Officer
|
Sell | 3.0K | $1.1M |
| Jul 22, 2026 | Paul E Munson
Officer
|
Sell | 1.5K | $564.1K |
| Jul 22, 2026 | Paul E Munson
Officer
|
Option | 1.5K | $192.4K |
| Jul 22, 2026 | David Donnay Rowland
Chief Investment Officer
|
Option | 5.0K | $662.9K |
| Jul 21, 2026 | Mojgan M Lefebvre
Chief Technology Officer
|
Sell | 16.3K | $6.0M |
| Jul 21, 2026 | Daniel S. Frey
Chief Financial Officer
|
Sell | 14.0K | $5.2M |
| Jul 21, 2026 | Michael Frederick Klein
Officer
|
Sell | 6.0K | $2.2M |
| Jul 21, 2026 | Daniel S. Frey
Chief Financial Officer
|
Option | 14.0K | $2.1M |
| Jul 21, 2026 | Michael Frederick Klein
Officer
|
Option | 6.0K | $839.0K |
| Jul 21, 2026 | Mojgan M Lefebvre
Chief Technology Officer
|
Option | 16.3K | $2.2M |
| Jun 30, 2026 | Russell G Golden
Director
|
Grant | 140 | $46.3K |
| Jun 30, 2026 | Elizabeth E Robinson
Director
|
Grant | 132 | $43.8K |
| May 26, 2026 | Michael Frederick Klein
Officer
|
Sell | 10.0K | $3.1M |
| May 26, 2026 | Michael Frederick Klein
Officer
|
Option | 10.0K | $1.3M |
| May 22, 2026 | Andy F Bessette
Officer
|
Sell | 4.3K | $1.3M |
| May 22, 2026 | Andy F Bessette
Officer
|
Option | 4.3K | $804.2K |
| Apr 30, 2026 | Avrohom J Kess
Officer
|
Grant | 1.0K | - |
| Apr 28, 2026 | Avrohom J Kess
Officer
|
Sell | 6.7K | $2.1M |
| Apr 28, 2026 | William H Heyman
Officer
|
Sell | 1.6K | $483.7K |
| Apr 28, 2026 | William H Heyman
Officer
|
Option | 1.6K | $294.3K |
| Apr 28, 2026 | Avrohom J Kess
Officer
|
Option | 27.7K | $3.9M |
| Apr 23, 2026 | Laurie J Thomsen
Director
|
Grant | 631 | - |
| Apr 20, 2026 | Michael Frederick Klein
Officer
|
Sell | 10.0K | $3.0M |
| Apr 20, 2026 | Jeffrey P Klenk
Officer
|
Sell | 6.4K | $2.0M |
| Apr 20, 2026 | Diane Kurtzman
Officer
|
Sell | 2.9K | $870.0K |
| Apr 20, 2026 | Avrohom J Kess
Officer
|
Grant | 2.1K | - |
| Apr 20, 2026 | Michael Frederick Klein
Officer
|
Option | 10.0K | $1.3M |
| Apr 20, 2026 | Diane Kurtzman
Officer
|
Option | 1.4K | $183.9K |
| Mar 31, 2026 | Russell G Golden
Director
|
Grant | 158 | $46.2K |
| Mar 31, 2026 | Elizabeth E Robinson
Director
|
Grant | 149 | $43.7K |
| Feb 26, 2026 | Maria Olivo
Officer
|
Sell | 10.4K | $3.2M |
| Feb 26, 2026 | David Donnay Rowland
Chief Investment Officer
|
Sell | 4.7K | $1.5M |
| Feb 26, 2026 | Maria Olivo
Officer
|
Option | 10.4K | $1.2M |
| Feb 26, 2026 | David Donnay Rowland
Chief Investment Officer
|
Option | 4.7K | $597.0K |
| Feb 25, 2026 | Paul E Munson
Officer
|
Sell | 3.7K | $1.1M |
| Feb 25, 2026 | Paul E Munson
Officer
|
Option | 2.8K | $353.3K |
| Feb 23, 2026 | William H Heyman
Officer
|
Sell | 5.0K | $1.5M |
| Feb 23, 2026 | William H Heyman
Officer
|
Option | 5.0K | $912.0K |
| Feb 20, 2026 | Gregory C Toczydlowski
Officer
|
Sell | 12.2K | $3.7M |
| Feb 20, 2026 | Daniel S. Frey
Chief Financial Officer
|
Sell | 8.0K | $2.4M |
| Feb 20, 2026 | Avrohom J Kess
Officer
|
Sell | 4.8K | $1.4M |
| Feb 20, 2026 | Avrohom J Kess
Officer
|
Option | 20.0K | $2.8M |
| Feb 20, 2026 | Daniel Tei-Hwa Yin
Chief Investment Officer
|
Option | 8.5K | $1.0M |
| Feb 19, 2026 | Mojgan M Lefebvre
Officer
|
Sell | 5.8K | $1.7M |
| Feb 18, 2026 | Andy F Bessette
Officer
|
Grant | 8.2K | - |
| Feb 18, 2026 | Daniel S. Frey
Chief Financial Officer
|
Grant | 16.1K | - |
| Feb 18, 2026 | William H Heyman
Officer
|
Grant | 10.1K | - |
| Feb 18, 2026 | Avrohom J Kess
Officer
|
Grant | 19.1K | - |
| Feb 18, 2026 | Michael Frederick Klein
Officer
|
Grant | 21.5K | - |
| Feb 18, 2026 | Jeffrey P Klenk
Officer
|
Grant | 12.0K | - |
| Feb 18, 2026 | Diane Kurtzman
Officer
|
Grant | 6.0K | - |
| Feb 18, 2026 | Mojgan M Lefebvre
Officer
|
Grant | 12.0K | - |
| Feb 18, 2026 | Paul E Munson
Officer
|
Grant | 1.3K | - |
| Feb 18, 2026 | Maria Olivo
Officer
|
Grant | 13.9K | - |
| Feb 18, 2026 | David Donnay Rowland
Chief Investment Officer
|
Grant | 9.2K | - |
| Feb 18, 2026 | Alan D Schnitzer
Chief Executive Officer
|
Grant | 95.7K | - |
| Feb 18, 2026 | Gregory C Toczydlowski
Officer
|
Grant | 22.8K | - |
| Feb 18, 2026 | Daniel Tei-Hwa Yin
Chief Investment Officer
|
Grant | 9.2K | - |
| Feb 17, 2026 | Andy F Bessette
Officer
|
Sell | 6.0K | $1.8M |
| Feb 17, 2026 | William H Heyman
Officer
|
Sell | 1.0K | $300.0K |
| Feb 17, 2026 | Andy F Bessette
Officer
|
Option | 6.0K | $1.1M |
| Feb 17, 2026 | Andy F Bessette
Officer
|
Grant | 417 | - |
| Feb 17, 2026 | William H Heyman
Officer
|
Option | 1.0K | $172.5K |
| Feb 6, 2026 | Maria Olivo
Officer
|
Sell | 10.4K | $3.1M |
| Feb 6, 2026 | Michael Frederick Klein
Officer
|
Sell | 10.0K | $3.0M |
| Feb 6, 2026 | William H Heyman
Officer
|
Sell | 6.0K | $1.8M |
| Feb 6, 2026 | William H Heyman
Officer
|
Option | 6.0K | $1.0M |
| Feb 6, 2026 | Michael Frederick Klein
Officer
|
Option | 10.0K | $1.3M |
| Feb 6, 2026 | Maria Olivo
Officer
|
Option | 10.4K | $1.2M |
| Feb 4, 2026 | Alan D Schnitzer
Chief Executive Officer
|
Sell | 55.7K | $16.4M |
| Feb 4, 2026 | Alan D Schnitzer
Chief Executive Officer
|
Option | 216.2K | $27.3M |
| Feb 3, 2026 | Russell G Golden
Director
|
Grant | 729 | $210.1K |
| Feb 3, 2026 | Thomas B Leonardi
Director
|
Grant | 729 | $210.1K |
| Feb 3, 2026 | Clarencejr Otis
Director
|
Grant | 729 | $210.1K |
| Feb 3, 2026 | Elizabeth E Robinson
Director
|
Grant | 729 | $210.1K |
| Feb 3, 2026 | Rafael Santana
Director
|
Grant | 729 | $210.1K |
| Feb 3, 2026 | Todd C Schermerhorn
Director
|
Grant | 729 | $210.1K |
| Feb 3, 2026 | Kralingen Bridget Anne Van
Director
|
Grant | 729 | $210.1K |
| Feb 3, 2026 | David Scott Williams
Director
|
Grant | 729 | $210.1K |
| Jan 23, 2026 | Jeffrey P Klenk
Officer
|
Sell | 16.7K | $4.7M |
| Jan 23, 2026 | Jeffrey P Klenk
Officer
|
Option | 16.7K | $2.3M |
| Dec 31, 2025 | Russell G Golden
Director
|
Grant | 159 | $46.3K |
| Dec 31, 2025 | Elizabeth E Robinson
Director
|
Grant | 150 | $43.8K |
| Nov 26, 2025 | Maria Olivo
Officer
|
Sell | 8.9K | $2.6M |
| Nov 26, 2025 | Andy F Bessette
Officer
|
Grant | 400 | - |
| Nov 26, 2025 | Maria Olivo
Officer
|
Option | 8.9K | $1.1M |
| Nov 25, 2025 | William H Heyman
Officer
|
Sell | 4.0K | $1.2M |
| Nov 25, 2025 | William H Heyman
Officer
|
Option | 4.0K | $690.0K |
| Nov 25, 2025 | Maria Olivo
Officer
|
Grant | 520 | - |
| Nov 24, 2025 | Diane Kurtzman
Officer
|
Sell | 4.8K | $1.4M |
| Nov 24, 2025 | Diane Kurtzman
Officer
|
Option | 4.8K | $606.3K |
| Nov 21, 2025 | David Donnay Rowland
Chief Investment Officer
|
Sell | 5.0K | $1.5M |
| Nov 21, 2025 | William H Heyman
Officer
|
Sell | 2.0K | $583.0K |
| Nov 21, 2025 | William H Heyman
Officer
|
Option | 2.0K | $345.0K |
| Nov 21, 2025 | David Donnay Rowland
Chief Investment Officer
|
Option | 5.0K | $630.9K |
| Nov 13, 2025 | William H Heyman
Officer
|
Sell | 3.8K | $1.1M |
| Nov 13, 2025 | William H Heyman
Officer
|
Option | 3.8K | $590.7K |
| Nov 11, 2025 | William H Heyman
Officer
|
Sell | 7.0K | $2.0M |
| Nov 11, 2025 | William H Heyman
Officer
|
Option | 7.0K | $978.8K |
| Nov 6, 2025 | Daniel S. Frey
Chief Financial Officer
|
Sell | 25.0K | $7.0M |
| Nov 6, 2025 | Daniel S. Frey
Chief Financial Officer
|
Option | 25.0K | $3.5M |
| Oct 28, 2025 | Michael Frederick Klein
Officer
|
Sell | 8.6K | $2.3M |
| Oct 28, 2025 | Michael Frederick Klein
Officer
|
Option | 8.6K | $1.1M |
| Sep 30, 2025 | Russell G Golden
Director
|
Grant | 165 | $46.3K |
| Sep 30, 2025 | Elizabeth E Robinson
Director
|
Grant | 156 | $43.8K |
| Aug 22, 2025 | Mojgan M Lefebvre
Chief Operating Officer
|
Sell | 16.8K | $4.7M |
| Aug 22, 2025 | William H Heyman
Officer
|
Sell | 2.0K | $557.0K |
| Aug 22, 2025 | William H Heyman
Officer
|
Option | 2.0K | $279.7K |
| Aug 22, 2025 | Mojgan M Lefebvre
Chief Operating Officer
|
Option | 16.8K | $2.2M |
| Aug 18, 2025 | David Donnay Rowland
Chief Investment Officer
|
Grant | 2.0K | - |
| Aug 7, 2025 | Andy F Bessette
Officer
|
Sell | 7.7K | $2.1M |
| Aug 7, 2025 | Andy F Bessette
Officer
|
Option | 7.7K | $1.3M |
| Aug 4, 2025 | Michael Frederick Klein
Officer
|
Sell | 10.0K | $2.6M |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.